Boston Scientific Corporation
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2008 | $6.74B | $13.17B | $1.64B |
| FY2009 | $5.92B | $12.30B | $864.0M |
| FY2010 | $5.45B | $11.30B | $213.0M |
| FY2011 | $4.20B | $11.35B | $267.0M |
| FY2012 | $4.20B | $6.87B | $207.0M |
| FY2013 | $4.20B | $6.54B | $217.0M |
| FY2014 | $4.20B | $6.46B | $587.0M |
| FY2015 | $5.65B | $6.32B | $319.0M |
| FY2016 | $5.42B | $6.73B | $196.0M |
| FY2017 | $3.82B | $7.01B | $188.0M |
| FY2018 | $4.80B | $8.73B | $146.0M |
| FY2019 | $8.59B | $13.88B | $217.0M |
| FY2020 | $9.13B | $15.33B | $1.73B |
| FY2021 | $8.80B | $16.62B | $1.93B |
| FY2022 | $8.92B | $17.57B | $928.0M |
| FY2023 | $8.57B | $19.28B | $865.0M |
| FY2024 | $8.97B | $21.77B | $414.0M |
| FY2025 | $11.14B | $24.23B | $1.97B |